Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 1
2016 6
2017 6
2019 3
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Results by year
Filters applied: . Clear all
Page 1
Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1.
D'Alterio C, Buoncervello M, Ieranò C, Napolitano M, Portella L, Rea G, Barbieri A, Luciano A, Scognamiglio G, Tatangelo F, Anniciello AM, Monaco M, Cavalcanti E, Maiolino P, Romagnoli G, Arra C, Botti G, Gabriele L, Scala S. D'Alterio C, et al. Among authors: buoncervello m. J Exp Clin Cancer Res. 2019 Oct 28;38(1):432. doi: 10.1186/s13046-019-1420-8. J Exp Clin Cancer Res. 2019. PMID: 31661001 Free PMC article.
Preclinical models in the study of sex differences.
Buoncervello M, Marconi M, Carè A, Piscopo P, Malorni W, Matarrese P. Buoncervello M, et al. Clin Sci (Lond). 2017 Mar 1;131(6):449-469. doi: 10.1042/CS20160847. Clin Sci (Lond). 2017. PMID: 28265036 Review.
CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis.
Ieranò C, Portella L, Lusa S, Salzano G, D'Alterio C, Napolitano M, Buoncervello M, Macchia D, Spada M, Barbieri A, Luciano A, Barone MV, Gabriele L, Caraglia M, Arra C, De Rosa G, Scala S. Ieranò C, et al. Among authors: buoncervello m. Nanoscale. 2016 Apr 14;8(14):7562-71. doi: 10.1039/c5nr06335c. Nanoscale. 2016. PMID: 26983756
Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer.
Santagata S, Napolitano M, D'Alterio C, Desicato S, Maro SD, Marinelli L, Fragale A, Buoncervello M, Persico F, Gabriele L, Novellino E, Longo N, Pignata S, Perdonà S, Scala S. Santagata S, et al. Among authors: buoncervello m. Oncotarget. 2017 Aug 19;8(44):77110-77120. doi: 10.18632/oncotarget.20363. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100374 Free PMC article.
3D Microfluidic model for evaluating immunotherapy efficacy by tracking dendritic cell behaviour toward tumor cells.
Parlato S, De Ninno A, Molfetta R, Toschi E, Salerno D, Mencattini A, Romagnoli G, Fragale A, Roccazzello L, Buoncervello M, Canini I, Bentivegna E, Falchi M, Bertani FR, Gerardino A, Martinelli E, Natale C, Paolini R, Businaro L, Gabriele L. Parlato S, et al. Among authors: buoncervello m. Sci Rep. 2017 Apr 24;7(1):1093. doi: 10.1038/s41598-017-01013-x. Sci Rep. 2017. PMID: 28439087 Free PMC article.
Biphasic effects of propranolol on tumour growth in B16F10 melanoma-bearing mice.
Maccari S, Buoncervello M, Rampin A, Spada M, Macchia D, Giordani L, Stati T, Bearzi C, Catalano L, Rizzi R, Gabriele L, Marano G. Maccari S, et al. Among authors: buoncervello m. Br J Pharmacol. 2017 Jan;174(2):139-149. doi: 10.1111/bph.13662. Epub 2016 Nov 30. Br J Pharmacol. 2017. PMID: 27792834 Free PMC article.
Antitumor Effects of Epidrug/IFNα Combination Driven by Modulated Gene Signatures in Both Colorectal Cancer and Dendritic Cells.
Fragale A, Romagnoli G, Licursi V, Buoncervello M, Del Vecchio G, Giuliani C, Parlato S, Leone C, De Angelis M, Canini I, Toschi E, Belardelli F, Negri R, Capone I, Presutti C, Gabriele L. Fragale A, et al. Among authors: buoncervello m. Cancer Immunol Res. 2017 Jul;5(7):604-616. doi: 10.1158/2326-6066.CIR-17-0080. Epub 2017 Jun 14. Cancer Immunol Res. 2017. PMID: 28615266 Free article.
16 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page